跳到正文
Med· Ottaiano·收录于· 6 天前

When the standard changes during the trial: Reflections on targeted therapy in FGFR2-rearranged cholangiocarcinoma

When the standard changes during the trial: Reflections on targeted therapy in FGFR2-rearranged cholangiocarcinoma

来源:Med · doi.org